 immunolog aspect carbamazepin treatment epilept patient immun abnorm epilept patient antiepilept drug a phenytoin pht decreas serum iga igm level decreas blastic transform lymphocyt phytohemoagglutinin pha effect carbamazepin cbz immun respons effect cbz immunolog paramet serum concentr iga igg igm phagocytosi properti polymorphonuclear leukocyt pmn cytotox activ natur killer cell respons lymphocyt mitogen agent forti healthi individu epilept patient carbamazepin cbz monotherapi age rang year studi student test data cbz effect serum immunoglobulin concentr lymphocyt reactiv pha mitogen cbz signific enhanc phagocytosi properti pmn increas natur killer NK cell activ neg effect cbz therapi immun system studi